Ex-OpenAI science lead Kevin Weil launches Warp Sciences with $215M to automate drug-discovery wet labs
Former OpenAI science lead Kevin Weil has launched Warp Sciences, an AI startup that trains robots to synthesize and test promising drug compounds. Weil announced on X that the company raised $215 million at an $865 million valuation. The round was led by Lightspeed, with participation from IVP, Premji Invest and Lux Capital. Warp Science…